| Literature DB >> 33173536 |
Chenchen Xiong1, Shaoping Sun2, Weili Jiang1, Lei Ma1, Junpeng Zhang3.
Abstract
Autism spectrum disorder (ASD) is a class of neurodevelopmental disorders characterized by genetic and environmental risk factors. The pathogenesis of ASD has a strong genetic basis, consisting of rare de novo or inherited variants among a variety of multiple molecules. Previous studies have shown that microRNAs (miRNAs) are involved in neurogenesis and brain development and are closely associated with the pathogenesis of ASD. However, the regulatory mechanisms of miRNAs in ASD are largely unclear. In this work, we present a stepwise method, ASDmiR, for the identification of underlying pathogenic genes, networks, and modules associated with ASD. First, we conduct a comparison study on 12 miRNA target prediction methods by using the matched miRNA, lncRNA, and mRNA expression data in ASD. In terms of the number of experimentally confirmed miRNA-target interactions predicted by each method, we choose the best method for identifying miRNA-target regulatory network. Based on the miRNA-target interaction network identified by the best method, we further infer miRNA-target regulatory bicliques or modules. In addition, by integrating high-confidence miRNA-target interactions and gene expression data, we identify three types of networks, including lncRNA-lncRNA, lncRNA-mRNA, and mRNA-mRNA related miRNA sponge interaction networks. To reveal the community of miRNA sponges, we further infer miRNA sponge modules from the identified miRNA sponge interaction network. Functional analysis results show that the identified hub genes, as well as miRNA-associated networks and modules, are closely linked with ASD. ASDmiR is freely available at https://github.com/chenchenxiong/ASDmiR.Entities:
Keywords: autism spectrum disorder; lncRNA; mRNA; miRNA; miRNA regulation
Year: 2020 PMID: 33173536 PMCID: PMC7591752 DOI: 10.3389/fgene.2020.562971
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
FIGURE 1The workflow of ASDmiR. In Step 1, by integrating expression data of differential miRNAs, lncRNAs, and mRNAs and putative miRNA–target interactions, we identify miRNA–target regulatory networks using 12 existing computational methods. The miRNA–target regulatory network predicted by the best method is used for identifying miRNA–target regulatory modules. In Step 2, based on putative miRNA–mRNA interactions and gene expression data, we infer miRNA sponge interaction network using the sensitivity partial Pearson correlation method. Furthermore, we identify miRNA sponge modules from the identified miRNA sponge interaction network by using the Markov cluster algorithm. In Step 3, we conduct functional analysis of the identified miRNA-associated networks and modules. Green rhombic, pink circle, and purple triangle nodes represent miRNAs, mRNAs, and lncRNAs, respectively.
FIGURE 2Comparison in terms of the number of confirmed miRNA–target interactions using 12 miRNA–target prediction methods. (A) The number of validated miRNA–target interactions in the case of top 50 miRNA–target interactions of each miRNA. (B) The number of validated miRNA–target interactions in the case of top 100 miRNA–target interactions of each miRNA. (C) The number of validated miRNA–target interactions in the case of top 150 miRNA–target interactions of each miRNA. (D) The number of validated miRNA–target interactions in the case of top 200 miRNA–target interactions of each miRNA. The numbers in the white circle denote the overlap of validated miRNA–target interactions by 12 computational methods.
FIGURE 3Power law degree distribution of the identified miRNA sponge interaction networks. (A–E) Node degree distribution of the identified miRNA sponge interaction networks using different SC cutoffs from 0.1 to 0.3 with a step of 0.05. (F) Summary table of power law degree distribution under different SC cutoffs.
FIGURE 4Visualization and functional enrichment analysis of hub miRNA regulatory network. (A) Hub miRNA regulatory network. Green rhombic, pink circle, and purple triangle nodes denote miRNAs, mRNAs, and lncRNAs, respectively. (B) ASD-related enriched terms related to the target genes of hub miRNAs.
Disease and functional enriched terms of top 20 largest miRNA–target regulatory modules related to ASD.
| Items | Descriptions | Module ID | Evidence |
| umls:C1378703 | Renal carcinoma | 1, 8, 9, 19 | |
| umls:C0003469 | Anxiety disorders | 19 | |
| GO:0000380 | Alternative mRNA splicing, via spliceosome | 1, 2, 4, 6 | |
| GO:0007623 | Circadian rhythm | 1, 8 | |
| GO:0120111 | Neuron projection cytoplasm | 1, 2 | |
| GO:0099640 | Axodendritic protein transport | 1, 2 | |
| hsa03040 | Spliceosome | 5, 11, 12, 15, 16, 17, 19 | |
| R-HSA-210500 | Glutamate neurotransmitter release cycle | 5, 14 | |
| R-HSA-165159 | mTOR signaling | 5 |
Disease and functional enriched terms of miRNA sponge modules related to ASD.
| Module ID | Items | Description | Adjusted |
| 1 | GO:0061437 | Renal system vasculature development | 3.06E-02 |
| GO:0071364 | Cellular response to epidermal growth factor stimulus | 3.06E-02 | |
| GO:1903844 | Regulation of cellular response to transforming growth factor β stimulus | 4.09E-02 | |
| R-HSA-380972 | Energy dependent regulation of mTOR by LKB1-AMPK | 1.36E-02 | |
| R-HSA-165159 | mTOR signaling | 1.68E-02 | |
| R-HSA-198933 | Immunoregulatory interactions between a Lymphoid and a non-lymphoid cell | 4.90E-02 | |
| 2 | DOID:10155 | Intestinal cancer | 3.75E-02 |
| umls:C1845055 | α-Thalassemia/mental retardation syndrome, non-deletion type, X-linked | 2.47E-02 | |
| GO:0000380 | Alternative mRNA splicing, via spliceosome | 4.23E-02 | |
| 3 | GO:0034134 | Toll-like receptor 2 signaling pathway | 3.33E-04 |
| GO:0002758 | Innate immune response-activating signal transduction | 2.82E-02 | |
| GO:0007616 | Long-term memory | 2.97E-02 | |
| GO:0000380 | Alternative mRNA splicing, via spliceosome | 3.71E-02 | |
| hsa03040 | Spliceosome | 2.61E-02 | |
| R-HSA-5260271 | Diseases of immune system | 3.03E-02 | |
| R-HSA-1236974 | ER-phagosome pathway | 4.66E-02 | |
| R-HSA-168179 | Toll-like receptor TLR1:TLR2 cascade | 4.66E-02 | |
| 4 | GO:0000784 | Nuclear chromosome, telomeric region | 8.97E-03 |
| GO:0005912 | Adhere junction | 1.96E-02 | |
| 5 | GO:0099640 | Axodendritic protein transport | 4.86E-02 |
| GO:0042754 | Negative regulation of circadian rhythm | 4.86E-02 | |
| GO:1900016 | Negative regulation of cytokine production involved in inflammatory response | 4.86E-02 | |
| GO:0006658 | Phosphatidylserine metabolic process | 4.86E-02 | |
| GO:0002534 | Cytokine production involved in inflammatory response | 4.86E-02 | |
| R-HSA-8950505 | Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | 3.64E-02 | |
| 6 | GO:0000783 | Nuclear telomere cap complex | 4.43E-02 |
| R-HSA-1980145 | Signaling by NOTCH2 | 3.66E-02 | |
| R-HSA-177929 | Signaling by EGFR | 3.66E-02 | |
| R-HSA-2644603 | Signaling by NOTCH1 in Cancer | 3.66E-02 | |
| umls:C0267446 | Acute gastroenteritis | 4.81E-02 | |
| umls:C0588008 | Severe depression | 4.81E-02 | |
| 7 | GO:0005930 | Axoneme | 3.05E-02 |
| 8 | umls:C0027889 | Hereditary sensory and autonomic neuropathies | 1.19E-02 |
| umls:C0235025 | Peripheral motor neuropathy | 1.68E-02 | |
| umls:C0151313 | Sensory neuropathy | 1.93E-02 | |
| umls:C1270972 | Mild cognitive disorder | 3.32E-02 | |
| GO:0007173 | Epidermal growth factor receptor signaling pathway | 4.00E-02 | |
| GO:0038127 | ERBB signaling pathway | 4.25E-02 | |
| GO:0002433 | Immune response-regulating cell surface receptor signaling pathway involved in phagocytosis | 4.25E-02 | |
| GO:0038094 | Fc-gamma receptor signaling pathway | 4.25E-02 | |
| hsa04144 | Endocytosis | 8.81E-03 | |
| 9 | DOID:0060116 | Sensory system cancer | 4.63E-02 |
| GO:0000380 | Alternative mRNA splicing, via spliceosome | 8.07E-03 | |
| GO:0007050 | Cell cycle arrest | 3.34E-02 | |
| GO:0099640 | Axodendritic protein transport | 3.44E-02 | |
| GO:1904357 | Negative regulation of telomere maintenance via telomere lengthening | 4.29E-02 | |
| GO:0032839 | Dendrite cytoplasm | 4.62E-02 | |
| GO:0005925 | Focal adhesion | 4.62E-02 | |
| hsa04218 | Cellular senescence | 1.90E-02 | |
| hsa03040 | Spliceosome | 1.37E-02 | |
| R-HSA-9617828 | FOXO-mediated transcription of cell cycle genes | 3.36E-02 | |
| 10 | DOID:0050735 | X-linked disease | 1.31E-02 |
| GO:0005160 | Transforming growth factor β receptor binding | 3.18E-02 | |
| R-HSA-2173789 | TGF-β receptor signaling activates SMADs | 4.82E-02 | |
| R-HSA-2029480 | Fc-gamma receptor–dependent phagocytosis | 4.82E-02 |